Participants

AbbVie
Acorda Therapeutics
Adastra Pharmaceuticals
Adv. Regenerative Manufacturing Instit.
Akcea Therapeutics
Akili Interactive Labs
Alexandria Real Estate Equities
Alnylam Pharmaceuticals
Ambys Medicines
Apic Bio
Aquilo Partners
Arrakis Therapeutics
Artisan Biosciences
Baillie Gifford
BC Platforms
BioCentury
Bloomberg News
Boston Globe
Boston Univ.
Brigham Health
Broadview Ventures
CBT Advisors
Cedilla Therapeutics
Cellino
Cerevance, Inc.

Churchill Pharma LLC
Corvidia Therapeutics
CRISPR Therapeutics
CN Bio Innovations
Comet Therapeutics
CytoSite Biopharma
Dewpoint Therapeutics
Eli Lilly & Company
Elstar Therapeutics
EMD Serono
Evelo Biosciences
Evotec
Foley & Lardner
FORMA Therapeutics
Frazier Healthcare Partners
GNS Healthcare
GrayBella Capital
Halloran Consulting Group
iCarbonX
Ipsen
Ironwood Pharmaceuticals
IRX Therapeutics
JJDC
Johnson & Johnson
Kaleido Biosciences
Koch Institute at MIT
KSQ Therapeutics
Kytopen

Lumira Ventures
Lysosomal Therapeutics
MacDougall Biomedical Communications
Magenta Therapeutics
Merck
Mersana Therapeutics
Metera Pharmaceuticals
Millendo Therapeutics
Mirata Pharmaceuticals
MIT Media Lab
Momenta Pharmaceuticals
MRL Ventures Fund
Navitor Pharmaceuticals
Nocion Therapeutics
Novartis Instit. for Biomedical Rsh.
Novartis Venture Fund
Oncorus
Ovid Therapeutics Inc.
Oxford Finance LLC
Park Square Executive Search

Pear Therapeutics
Peptilogics
Phagelux
Potenza Therapuetics
Prognos
Revolutionary Farms
RMG Associates
Roivant Pharma
Rubius Therapeutics
Sage Therapeutics
Sanofi
Sarepta Therapeutics
Selecta Biosciences
Sensei Biotherapeutics
SmartPharm Therapeutics
SR One
Stat
Sunovion Pharmaceuticals
The Engine, MIT
Trieza Therapeutics
Twentyeight-Seven
United Neuroscience
Unity Biotechnology
USB
Versant Ventures
Visterra
Vivid Biosciences
Voyager Therapeutics